Fig. 4From: Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinomaPFS and OS according to change of neutrophil-to-lymphocyte ratio (NLR) at 6 weeks, separately by baseline NLR status (Low vs High, dichotomized at the median)Back to article page